Brief: Datinvest, GVB Biopharma And Irwin Naturals Enter Into Letter Of Intent For A Business Combination
31/03/2021 22:23
March 31 (Reuters) - Datinvest International Ltd DAIh.V :
* DATINVEST, GVB BIOPHARMA AND IRWIN NATURALS ENTER INTO
LETTER OF
INTENT FOR A BUSINESS COMBINATION
Source text for Eikon: ID:nCNWfXv0ca
Further company coverage: DAIh.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Irwin Naturals
See all newsBrief: FitLife Brands To Acquire Irwin Naturals
Brief: Irwin Naturals Q3 Adjusted EBITDA USD -1.651 Million
Brief: Repeat - Irwin Naturals Acquires Ketamine Media
Brief: Irwin Naturals Terminates Letter Of Intent For Business Combination With Braxia Scientific
Brief: Irwin Naturals Secures $40 Mln Financing For Its Current Operations